Independent Advisor Alliance Novartis Ag Transaction History

Independent Advisor Alliance

  • $3.71 Billion
  • Q3 2025

A detailed history of Independent Advisor Alliance transactions in Novartis Ag stock. As of the latest transaction made, Independent Advisor Alliance holds 5,383 shares of NVS stock, worth $708,133. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,383
Previous 4,880 10.31%
Holding current value
$708,133
Previous $590,000 16.95%
% of portfolio
0.02%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
BUY
$113.5 - $129.73 $57,090 - $65,254
503 Added 10.31%
5,383 $690,000
Q2 2025

Aug 11, 2025
BUY
$101.96 - $121.01 $35,278 - $41,869
346 Added 7.63%
4,880 $590,000
Q1 2025

May 12, 2025
BUY
$97.14 - $115.57 $16,708 - $19,878
172 Added 3.94%
4,534 $505,000
Q4 2024

Feb 07, 2025
BUY
$96.78 - $117.18 $79,940 - $96,790
826 Added 23.36%
4,362 $424,000
Q3 2024

Nov 12, 2024
BUY
$106.13 - $120.89 $4,351 - $4,956
41 Added 1.17%
3,536 $406,000
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $18,051 - $20,937
-195 Reduced 5.28%
3,495 $372,000
Q1 2024

May 08, 2024
SELL
$95.27 - $108.47 $86,505 - $98,490
-908 Reduced 19.75%
3,690 $356,000
Q4 2023

Feb 08, 2024
BUY
$92.27 - $101.54 $32,294 - $35,539
350 Added 8.24%
4,598 $464,000
Q3 2023

Oct 24, 2023
SELL
$94.73 - $105.13 $5,494 - $6,097
-58 Reduced 1.35%
4,248 $432,000
Q2 2023

Jul 28, 2023
SELL
$92.52 - $104.91 $17,948 - $20,352
-194 Reduced 4.31%
4,306 $434,000
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $360,135 - $417,645
4,500 New
4,500 $414,000
Q3 2022

Nov 04, 2022
BUY
$74.61 - $87.26 $20,816 - $24,345
279 Added 6.09%
4,863 $370,000
Q2 2022

Aug 04, 2022
SELL
$80.52 - $93.75 $40,179 - $46,781
-499 Reduced 9.82%
4,584 $387,000
Q1 2022

May 06, 2022
SELL
$80.11 - $90.62 $8,892 - $10,058
-111 Reduced 2.14%
5,083 $446,000
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $59,137 - $65,392
-742 Reduced 12.5%
5,194 $454,000
Q3 2021

Nov 01, 2021
BUY
$81.78 - $95.14 $20,445 - $23,785
250 Added 4.4%
5,936 $485,000
Q2 2021

Aug 12, 2021
BUY
$85.24 - $94.15 $81,745 - $90,289
959 Added 20.29%
5,686 $519,000
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $3,590 - $4,234
43 Added 0.92%
4,727 $404,000
Q4 2020

Feb 11, 2021
BUY
$78.07 - $94.43 $36,927 - $44,665
473 Added 11.23%
4,684 $442,000
Q3 2020

Nov 04, 2020
SELL
$82.14 - $91.0 $7,967 - $8,827
-97 Reduced 2.25%
4,211 $366,000
Q2 2020

Aug 06, 2020
BUY
$80.93 - $91.1 $647 - $728
8 Added 0.19%
4,308 $376,000
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $8,692 - $12,178
-123 Reduced 2.78%
4,300 $355,000
Q4 2019

Feb 07, 2020
BUY
$84.35 - $95.37 $21,593 - $24,414
256 Added 6.14%
4,423 $419,000
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $15,055 - $16,589
176 Added 4.41%
4,167 $362,000
Q2 2019

Aug 12, 2019
BUY
$75.4 - $92.8 $31,894 - $39,254
423 Added 11.86%
3,991 $364,000
Q1 2019

May 07, 2019
SELL
$75.32 - $86.15 $24,930 - $28,515
-331 Reduced 8.49%
3,568 $343,000
Q4 2018

Feb 12, 2019
SELL
$73.66 - $82.02 $47,879 - $53,313
-650 Reduced 14.29%
3,899 $335,000
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $12,584 - $14,556
-188 Reduced 3.97%
4,549 $342,000
Q2 2018

Aug 08, 2018
BUY
$64.91 - $73.36 $27,586 - $31,178
425 Added 9.86%
4,737 $317,000
Q1 2018

May 15, 2018
BUY
$70.39 - $84.15 $19,779 - $23,646
281 Added 6.97%
4,312 $343,000
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $5,497 - $5,900
76 Added 1.92%
4,031 $347,000
Q3 2017

Nov 15, 2017
SELL
$74.14 - $77.27 $618,846 - $644,972
-8,347 Reduced 67.85%
3,955 $338,000
Q2 2017

Aug 14, 2017
BUY
N/A
12,302
12,302 $325,000

Others Institutions Holding NVS

# of Institutions
1,599
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Independent Advisor Alliance Portfolio

Follow Independent Advisor Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email